Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 221-331-9 | CAS number: 3069-19-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30 November 2018 to 07 May 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- July 22, 2010
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Bayrisches Landesamt für Gesundheit und Lebensmittelsicherheit, Schwabach, Germany
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Hexyltrimethoxysilane
- EC Number:
- 221-331-9
- EC Name:
- Hexyltrimethoxysilane
- Cas Number:
- 3069-19-0
- Molecular formula:
- C9H22O3Si
- IUPAC Name:
- hexyltrimethoxysilane
- Test material form:
- liquid
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd mice
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo, 5800 AN Venray, The Netherlands
- Females nulliparous and non-pregnant: yes
- Age at study initiation: 9–10 weeks
- Housing: animals were kept in groups of 5 animals in IVC cages, type II L, polysulphone cages on Altromin saw fibre bedding
- Diet: Altromin 1324 maintenance diet available ad libitum
- Water: tap water, sulphur acidified to a pH value of approx. 2.8 available ad libitum
- Acclimation period: 13 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%): 55 ± 10
- Air changes (per hr): at least 10 x
- Photoperiod (hrs dark / hrs light): 12 hours light, 12 hours dark
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25%, 50% (each diluted in AOO 4:1, v/v) and 100% (undiluted test item)
- No. of animals per dose:
- 5 mice / test group; 5 mice / control group
- Details on study design:
- PRE-SCREEN TESTS:
- Compound solubility: The maximum technically applicable concentration of the test item was found to be 100%. The maximum technically applicable concentration of the test item in the vehicle was found to be 50% in AOO.
- Irritation: The mice were observed daily for any clinical signs of local irritation at the application site. Excessive local irritation was indicated by an erythema score ≥ 3 and/or ear swelling of ≥ 25%. Neither signs of irritation nor excessive irritation at any application site could be detected in any animal.
- Systemic toxicity: The mice were observed daily for any clinical signs of systemic toxicity at the application site. Body weights were recorded pre-test and prior to termination. Cage-side observations included spontaneous activity, lethargy, recumbent position, convulsions, tremors, apnoea, asphyxia, vocalisation, diarrhoea, changes in the skin and fur, eyes and mucous membranes (salivation, discharge). No signs of systemic toxicity at any application site could be detected in any animal. All animals showed the expected weight development, which allows for a weight loss of up to 2 g throughout the duration of the prescreen test.
- Ear thickness measurements: Ear thickness measurements were performed on day 1 (pre-dose), day 3 (approximately 48 hours after the first dose) and day 6.
- Erythema scores: Both ears were observed for erythema and scored on a scale of 0 (no erythema) to 4 (severe erythema to eschar formation preventing grading of erytema). All animals were valued at erythema score 0.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: A substance is regarded as a 'sensitiser' in the LLNA if at least one concentration of the test item results in a 3-fold or greater increase in 3H-methyl thymidine - incorporation into lymph node cells of the test group animals, relative to that recorded for the lymph nodes of control group animals (Stimulation Index equal to or greater than 3.0).
TREATMENT PREPARATION AND ADMINISTRATION: Prior to the application and once a day thereafter all animals were observed in order to detect signs of toxicity, including dermal irritation at site of application. The animals were weighed prior to the application and at the end of the test period (prior to the treatment with 3HTdR). Each mouse was treated by topical application of 25 µL of the selected solution to the entire dorsal surface of each ear. Topical applications were performed once daily over three consecutive days. The first treatment day is defined as study day 1. Five days after the first topical application all mice were dosed with 3H-methyl thymidine by intravenous injection (tail vein) of 3H-methyl thymidine, diluted with phosphate buffered saline (PBS). Approximately 5 hours after the injection, all mice were sacrificed. The auricular lymph nodes were excised, weighed, individually pooled for each animal (2 lymph nodes per animal) and collected in PBS. A single cell suspension of pooled lymph node cells was prepared by gentle mechanical disaggregation through gauze. After washing the gauze with PBS, the cell suspension was pelleted in a centrifuge. The supernatant was discarded and the pellets were resuspended with PBS. This washing procedure was repeated. After the final wash each pellet was resuspended at approx. 4° C for approximately 18 hours for precipitation. Each precipitate was washed again, resuspended, and transferred into vials to be stored at room temperature overnight. The 3H-methyl thymidine – incorporation was measured in a ß-counter and expressed as the number of disintegrations per minute (DPM). Similarly, background 3H-methyl thymidine levels were also measured. Determination of radioactivity was performed individually for each animal. - Positive control substance(s):
- other: 1% phenylenediamine
- Statistics:
- None reported
Results and discussion
- Positive control results:
- The positive-control substance exceeded the stimulation index of 3 confirming the reliability of the test system.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- 0.8
- Test group / Remarks:
- 25%
- Key result
- Parameter:
- SI
- Value:
- 2.5
- Test group / Remarks:
- 50%
- Key result
- Parameter:
- SI
- Value:
- 3.2
- Test group / Remarks:
- 100%
- Key result
- Parameter:
- EC3
- Remarks:
- %
- Value:
- 85.71
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
The means of the lymph node weights per group showed relevant difference in the 50% and 100% test groups compared to the negative control. The mean weight of the lymph nodes were 2.9 mg at 25%, 4.5 mg at 50%, and 5.3 mg at 100%. The mean weight of the lymph nodes for the control group was 3.0 mg.
DETAILS ON STIMULATION INDEX CALCULATION
The stimulation indices were 0.8 at 25%, 2.5 at 50%, and 3.2 at 100%.
EC3 CALCULATION
The EC3 value was calculated to be at a test item concentration of 85.71 %, when using the SI values at the concentrations of 50% and 100%.
CLINICAL OBSERVATIONS:
All animals survived throughout the test period without showing any clinical signs.
BODY WEIGHTS
All animals showed the expected weight development, which allows for a weight loss of up to 2 g throughout the study.
Applicant's summary and conclusion
- Interpretation of results:
- other: Category 1B based on CLP criteria (EU criteria according to Regulation (EC) No. 1272/2008).
- Conclusions:
- In a local lymph node assay conducted according to OECD 429 and to GLP (reliability score 1), the test material is considered to be a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.